Why Greenleaf Therapeutics? Greenleaf Therapeutics is a subsidiary of Canopy USA, LLC, a leading vertically integrated, multi-state operator in the United States cannabis industry.
With the transition of Acreage Holdings to Canopy USA, LLC in December 2024, Canopy USA, LLC is now positioned to consolidate operations across its three business units - Wana, Jetty, and Acreage - realizing synergies, cost savings, and supporting growth in state-legal markets across the U.S.
Through coverage of key market segments including flower via Superflux, vape and concentrates via Jetty, edibles and beverages via Wana, and retail through The Botanist, Canopy USA, LLC is well positioned to accelerate growth with an emphasis on the Midwestern and Northeastern U.S.
markets.
As newly formed Canopy USA, LLC, we are building a stronger, more agile organization that will unlock greater opportunities across the growing US cannabis market.
Who you'll work for Greenleaf Therapeutics: Our Culture...